News

Never miss an opportunity with high-impact economic event coverage, expert commentary, videos, and more from our global market analysts.

29 December 2020 -

Strong Australasian Economic Data | Z Energy & NZR Dispute

The dispute between NZR and ZEL moved up a notch yesterday.

29 December 2020 -

Outlook for 2021 | A2 Milk & QBE Downgrades

We are constructive heading into 2021 given the backdrop of cheap money and an economic recovery boom. However, we remain cognizant of risks such as issues with vaccines, higher inflation/interest rates, and central bank / government policy missteps.

15 December 2020 -

Week Ahead | Briscoes Record Sales

The US FDA formally approved emergency use authorisation for Pfizer and BioNtech’s Covid-19 vaccine over the weekend. 

15 December 2020 -

Vaccines & Travel Bubbles | Air NZ – Back to Neutral

NZ Cabinet has agreed in-principle to establishing a travel bubble with Australia within the first three months of 2021. The arrangement will depend on there being “no significant change” in the Covid-19 situation in both countries, and the bubble getting

14 December 2020 -

Week Ahead, Bad New is Good News | Fonterra

Global markets continued to rally on Friday (S&P 500 index +0.9%) with major US market indices hitting all-time highs and small-cap stocks outperformed.

14 December 2020 -

Mixed Markets | Infratil to offload Tilt

A rally in cyclical stocks that has propelled global benchmarks to record highs in recent weeks lost momentum on Monday, but the Nasdaq hit another high as big tech stole the show.

14 December 2020 -

UK Rolls Out Vaccine | PGW Jumps, Infratil +19% on Takeover

A key sentiment indicator for US stocks has reached its most bullish level in two decades.

14 December 2020 -

Wall Street Slips | Scales Update

US stocks slipped from an all-time high on concern over dimming prospects for fresh stimulus amid resurgent coronavirus cases.

14 December 2020 -

Air Bnb Doubles on IPO | Appen Sinks

The big stock news in the US was the listing of Airbnb, which surged 115% from its $68 per share IPO price.